Alkermes(US:ALKS) Prnewswireยท2024-10-17 20:00Group 1 - Alkermes plc will host a conference call and webcast presentation on October 24, 2024, at 8:00 a.m. ET to discuss its third quarter financial results [1] - The webcast and accompanying slides will be available on Alkermes' website, and a replay will be accessible approximately two hours after the event [1] - The company is a global biopharmaceutical firm focused on developing innovative medicines in neuroscience, with a portfolio addressing alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder [2] Group 2 - Alkermes has a pipeline of clinical and preclinical candidates for neurological disorders, including narcolepsy and idiopathic hypersomnia [2] - The company is headquartered in Ireland, with additional offices in Massachusetts and a manufacturing facility in Ohio [2] - For investor relations inquiries, Jamie Constantine can be contacted at +1 781 873 2402 [2]